Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Bichet

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese familiesShih-Hua Lin, Daniel G Bichet, Sei Sasaki, et al.
Nephron. Physiology|October 10, 2009
Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidusDetlef Bockenhauer, Eric Carpentier, Driss Rochdi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2002
Intrafamilial phenotype variability in nephrogenic diabetes insipidusKarine Kalenga, Alexandre Persu, Eric Goffin, et al.
Drugs in R&D|September 20, 2021
The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor ProcessAneal Khan, Sandra M Sirrs, Daniel G Bichet, et al.
Scientific Reports|June 26, 2019
Disease-linked mutations alter the stoichiometries of HCN-KCNE2 complexesYoann Lussier, Oliver Fürst, Eva Fortea, et al.
Pediatric Nephrology (Berlin, Germany)|February 9, 2011
A patient with polyuria and hydronephrosis: questionGraciana Jaureguiberry, William Van't Hoff, Imran Mushtaq, et al.
Clinical Kidney Journal|June 13, 2015
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiologyDaniel G Bichet, Abdulah El Tarazi, Jessica Matar, et al.
Journal of the American Society of Nephrology : JASN|February 27, 2010
Oral tolvaptan is safe and effective in chronic hyponatremiaTomas Berl, Friederike Quittnat-Pelletier, Joseph G Verbalis, et al.
Pediatric Nephrology (Berlin, Germany)|March 19, 2009
Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidusReyhan El-Kares, Pierre-Alain Hueber, Miriam Blumenkrantz, et al.
Critical Reviews in Clinical Laboratory Sciences|March 18, 2024
G protein-coupled receptor (GPCR) gene variants and human genetic diseaseMiles D Thompson, Maire E Percy, David E C Cole, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese familiesShih-Hua Lin, Daniel G Bichet, Sei Sasaki, et al.
Nephron. Physiology|October 10, 2009
Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidusDetlef Bockenhauer, Eric Carpentier, Driss Rochdi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2002
Intrafamilial phenotype variability in nephrogenic diabetes insipidusKarine Kalenga, Alexandre Persu, Eric Goffin, et al.
Drugs in R&D|September 20, 2021
The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor ProcessAneal Khan, Sandra M Sirrs, Daniel G Bichet, et al.
Scientific Reports|June 26, 2019
Disease-linked mutations alter the stoichiometries of HCN-KCNE2 complexesYoann Lussier, Oliver Fürst, Eva Fortea, et al.
Pediatric Nephrology (Berlin, Germany)|February 9, 2011
A patient with polyuria and hydronephrosis: questionGraciana Jaureguiberry, William Van't Hoff, Imran Mushtaq, et al.
Clinical Kidney Journal|June 13, 2015
Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiologyDaniel G Bichet, Abdulah El Tarazi, Jessica Matar, et al.
Journal of the American Society of Nephrology : JASN|February 27, 2010
Oral tolvaptan is safe and effective in chronic hyponatremiaTomas Berl, Friederike Quittnat-Pelletier, Joseph G Verbalis, et al.
Pediatric Nephrology (Berlin, Germany)|March 19, 2009
Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidusReyhan El-Kares, Pierre-Alain Hueber, Miriam Blumenkrantz, et al.
Critical Reviews in Clinical Laboratory Sciences|March 18, 2024
G protein-coupled receptor (GPCR) gene variants and human genetic diseaseMiles D Thompson, Maire E Percy, David E C Cole, et al.
Pageof 15